RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
A new cost-effectiveness framework for modeling psoriasis treatments
Graham, C., Mollon, P., Miles, L., & McBride, D. (2015). A new cost-effectiveness framework for modeling psoriasis treatments. Value in Health, 18(3), A20-A20. https://doi.org/10.1016/j.jval.2015.03.126
As more psoriasis treatments come to market in both new and existing drug classes, health care payers will need assistance in determining the most cost-effective regimen or sequence of regimens to control budgets. We sought to devise a cost-effectiveness modeling structure that will aid in decision making by highlighting differentiating factors between drugs and meet the changing needs of payers.